I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL
The purpose of this study is to explore the efficacy and safety of Inotuzumab Ozogamicin in the treatment of minimal residual disease recurrence after HSCT of ALL patients.
- 0 views
- 12 Jul, 2023
- 2 locations
InO - A Retrospective Study of UK Patients With Leukaemia
The purpose of this study is to describe the demographics and clinical characteristics, treatment pathway, and effectiveness and safety of inotuzumab ozogamicin in patients with relapsed/refractory B-cell acute lymphoblastic leukaemia treated with inotuzumab ozogamicin in the real-world.
lymphoma
acute lymphoblastic leukemia
b-cell acute lymphoblastic leukemia
lymphoblastic leukemia
inotuzumab
- 0 views
- 16 Feb, 2024
- 3 locations